HEADER TRANSFERASE 01-OCT-17 6EM2 TITLE CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM TITLE 2 CRITECULUS GRISEUS IN COMPLEX WITH FASUDIL COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PKA C-ALPHA; COMPND 5 EC: 2.7.11.11; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRICETULUS GRISEUS; SOURCE 3 ORGANISM_COMMON: CHINESE HAMSTER; SOURCE 4 ORGANISM_TAXID: 10029; SOURCE 5 ORGAN: OVARY; SOURCE 6 TISSUE: OVARY; SOURCE 7 GENE: PRKACA; SOURCE 8 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 866768 KEYWDS TRANSFERASE, FASUDIL, COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.M.MUELLER,A.HEINE,G.KLEBE REVDAT 2 15-MAY-19 6EM2 1 COMPND JRNL REVDAT 1 10-OCT-18 6EM2 0 JRNL AUTH J.M.MUELLER,R.KIRSCHNER,A.GEYER,G.KLEBE JRNL TITL CONCEPTIONAL DESIGN OF SELF-ASSEMBLING BISUBSTRATE-LIKE JRNL TITL 2 INHIBITORS OF PROTEIN KINASE A RESULTING IN A BORONIC ACID JRNL TITL 3 GLUTAMATE LINKAGE JRNL REF ACS OMEGA 2019 JRNL REFN ESSN 2470-1343 JRNL DOI 10.1021/ACSOMEGA.8B02364 REMARK 2 REMARK 2 RESOLUTION. 1.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.12 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 91361 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.133 REMARK 3 R VALUE (WORKING SET) : 0.132 REMARK 3 FREE R VALUE : 0.153 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 4569 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.1472 - 4.0328 0.99 3123 165 0.1578 0.1523 REMARK 3 2 4.0328 - 3.2012 0.99 2993 157 0.1480 0.1424 REMARK 3 3 3.2012 - 2.7966 1.00 2967 157 0.1512 0.1520 REMARK 3 4 2.7966 - 2.5409 1.00 2946 155 0.1417 0.1661 REMARK 3 5 2.5409 - 2.3588 0.99 2915 153 0.1341 0.1554 REMARK 3 6 2.3588 - 2.2197 1.00 2925 154 0.1212 0.1513 REMARK 3 7 2.2197 - 2.1086 1.00 2924 154 0.1193 0.1460 REMARK 3 8 2.1086 - 2.0168 1.00 2906 153 0.1243 0.1412 REMARK 3 9 2.0168 - 1.9392 1.00 2900 152 0.1171 0.1590 REMARK 3 10 1.9392 - 1.8722 1.00 2923 154 0.1126 0.1447 REMARK 3 11 1.8722 - 1.8137 1.00 2873 152 0.1130 0.1266 REMARK 3 12 1.8137 - 1.7618 1.00 2905 152 0.1072 0.1531 REMARK 3 13 1.7618 - 1.7155 1.00 2902 153 0.1033 0.1342 REMARK 3 14 1.7155 - 1.6736 0.99 2874 151 0.1014 0.1459 REMARK 3 15 1.6736 - 1.6356 1.00 2885 152 0.1019 0.1270 REMARK 3 16 1.6356 - 1.6008 1.00 2898 153 0.0986 0.1529 REMARK 3 17 1.6008 - 1.5687 1.00 2889 152 0.1014 0.1378 REMARK 3 18 1.5687 - 1.5391 1.00 2863 151 0.1003 0.1220 REMARK 3 19 1.5391 - 1.5116 1.00 2912 153 0.1010 0.1275 REMARK 3 20 1.5116 - 1.4860 1.00 2863 150 0.1067 0.1520 REMARK 3 21 1.4860 - 1.4620 1.00 2875 152 0.1109 0.1596 REMARK 3 22 1.4620 - 1.4395 1.00 2879 151 0.1164 0.1457 REMARK 3 23 1.4395 - 1.4184 1.00 2888 152 0.1181 0.1821 REMARK 3 24 1.4184 - 1.3984 1.00 2890 152 0.1243 0.1586 REMARK 3 25 1.3984 - 1.3795 0.99 2819 149 0.1358 0.1858 REMARK 3 26 1.3795 - 1.3616 0.99 2883 152 0.1518 0.2000 REMARK 3 27 1.3616 - 1.3446 0.99 2869 151 0.1643 0.2260 REMARK 3 28 1.3446 - 1.3284 1.00 2840 149 0.1752 0.2426 REMARK 3 29 1.3284 - 1.3129 1.00 2863 151 0.1992 0.2396 REMARK 3 30 1.3129 - 1.2982 0.90 2600 137 0.2219 0.2618 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.110 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 12.990 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 2952 REMARK 3 ANGLE : 1.156 4025 REMARK 3 CHIRALITY : 0.223 427 REMARK 3 PLANARITY : 0.008 531 REMARK 3 DIHEDRAL : 21.026 1093 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6EM2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1200006612. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-AUG-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 91364 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.300 REMARK 200 RESOLUTION RANGE LOW (A) : 46.118 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 5.050 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04400 REMARK 200 FOR THE DATA SET : 19.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.50400 REMARK 200 FOR SHELL : 3.050 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES-BIS-TRIS, 75 MM LITHIUM REMARK 280 CHLORIDE, 1 MM DTT, 0.1 MM SODIUM EDTA, 0.25 MM MEGA 8, 23% V/V REMARK 280 METHANOL/WATER IN RESERVOIR, PH 6.9, VAPOR DIFFUSION, SITTING REMARK 280 DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.13500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.99100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.98350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.99100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.13500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.98350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 HIS A -1 REMARK 465 MET A 0 REMARK 465 GLY A 1 REMARK 465 ASN A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 LYS A 7 REMARK 465 LYS A 8 REMARK 465 GLY A 9 REMARK 465 SEP A 10 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 11 CG CD OE1 OE2 REMARK 470 GLN A 12 CG CD OE1 NE2 REMARK 470 LYS A 16 CD CE NZ REMARK 470 LYS A 29 NZ REMARK 470 GLU A 64 CG CD OE1 OE2 REMARK 470 LYS A 78 CE NZ REMARK 470 LYS A 81 CG CD CE NZ REMARK 470 LEU A 82 CD2 REMARK 470 LYS A 83 CD CE NZ REMARK 470 LYS A 105 CD CE NZ REMARK 470 ILE A 135 CD1 REMARK 470 GLN A 176 CG CD OE1 NE2 REMARK 470 GLN A 177 CG CD OE1 NE2 REMARK 470 LYS A 192 NZ REMARK 470 ARG A 194 NE CZ NH1 NH2 REMARK 470 PHE A 239 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ILE A 244 CD1 REMARK 470 GLN A 245 NE2 REMARK 470 GLU A 248 CD OE1 OE2 REMARK 470 LYS A 254 CG CD CE NZ REMARK 470 ARG A 256 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 285 CG CD CE NZ REMARK 470 LYS A 295 CD CE NZ REMARK 470 ILE A 303 CD1 REMARK 470 LYS A 309 NZ REMARK 470 GLU A 311 CD OE1 OE2 REMARK 470 LYS A 317 CD CE NZ REMARK 470 LYS A 319 CE NZ REMARK 470 ILE A 339 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 58 CG - SD - CE ANGL. DEV. = -10.7 DEGREES REMARK 500 ARG A 144 NE - CZ - NH1 ANGL. DEV. = -3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 99 105.69 -160.69 REMARK 500 ASP A 166 35.43 -141.30 REMARK 500 ASP A 184 87.62 71.45 REMARK 500 LEU A 273 43.17 -87.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 807 DISTANCE = 5.88 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue M77 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MPD A 402 DBREF 6EM2 A 0 350 UNP P25321 KAPCA_CRIGR 1 351 SEQADV 6EM2 GLY A -2 UNP P25321 EXPRESSION TAG SEQADV 6EM2 HIS A -1 UNP P25321 EXPRESSION TAG SEQRES 1 A 353 GLY HIS MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SEP SEQRES 2 A 353 GLU GLN GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS SEQRES 3 A 353 GLU GLU PHE LEU LYS LYS TRP GLU SER PRO SER GLN ASN SEQRES 4 A 353 THR ALA GLN LEU ASP HIS PHE ASP ARG ILE LYS THR LEU SEQRES 5 A 353 GLY THR GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS SEQRES 6 A 353 LYS GLU THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP SEQRES 7 A 353 LYS GLN LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR SEQRES 8 A 353 LEU ASN GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO SEQRES 9 A 353 PHE LEU VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER SEQRES 10 A 353 ASN LEU TYR MET VAL MET GLU TYR VAL PRO GLY GLY GLU SEQRES 11 A 353 MET PHE SER HIS LEU ARG ARG ILE GLY ARG PHE SEP GLU SEQRES 12 A 353 PRO HIS ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR SEQRES 13 A 353 PHE GLU TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP SEQRES 14 A 353 LEU LYS PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR SEQRES 15 A 353 ILE GLN VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS SEQRES 16 A 353 GLY ARG THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU SEQRES 17 A 353 ALA PRO GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA SEQRES 18 A 353 VAL ASP TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET SEQRES 19 A 353 ALA ALA GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE SEQRES 20 A 353 GLN ILE TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE SEQRES 21 A 353 PRO SER HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG SEQRES 22 A 353 ASN LEU LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN SEQRES 23 A 353 LEU LYS ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP SEQRES 24 A 353 PHE ALA THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS SEQRES 25 A 353 VAL GLU ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY SEQRES 26 A 353 ASP THR SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE SEQRES 27 A 353 ARG VAL SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE THR SEQRES 28 A 353 GLU PHE MODRES 6EM2 SEP A 139 SER MODIFIED RESIDUE MODRES 6EM2 TPO A 197 THR MODIFIED RESIDUE MODRES 6EM2 SEP A 338 SER MODIFIED RESIDUE HET SEP A 139 14 HET TPO A 197 17 HET SEP A 338 14 HET M77 A 401 37 HET MPD A 402 22 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM M77 5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE HETNAM MPD (4S)-2-METHYL-2,4-PENTANEDIOL HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE HETSYN M77 FASUDIL, (5-ISOQUINOLINESULFONYL)HOMOPIPERAZINE FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 1 TPO C4 H10 N O6 P FORMUL 2 M77 C14 H17 N3 O2 S FORMUL 3 MPD C6 H14 O2 FORMUL 4 HOH *307(H2 O) HELIX 1 AA1 GLN A 12 SER A 32 1 21 HELIX 2 AA2 GLN A 39 ASP A 41 5 3 HELIX 3 AA3 LYS A 76 LEU A 82 1 7 HELIX 4 AA4 GLN A 84 VAL A 98 1 15 HELIX 5 AA5 GLU A 127 GLY A 136 1 10 HELIX 6 AA6 SEP A 139 LEU A 160 1 22 HELIX 7 AA7 LYS A 168 GLU A 170 5 3 HELIX 8 AA8 THR A 201 LEU A 205 5 5 HELIX 9 AA9 ALA A 206 LEU A 211 1 6 HELIX 10 AB1 LYS A 217 GLY A 234 1 18 HELIX 11 AB2 GLN A 242 SER A 252 1 11 HELIX 12 AB3 SER A 262 LEU A 273 1 12 HELIX 13 AB4 ASP A 276 ARG A 280 5 5 HELIX 14 AB5 VAL A 288 ASN A 293 1 6 HELIX 15 AB6 HIS A 294 ALA A 298 5 5 HELIX 16 AB7 ASP A 301 GLN A 307 1 7 SHEET 1 AA1 5 PHE A 43 THR A 51 0 SHEET 2 AA1 5 GLY A 55 HIS A 62 -1 O LEU A 59 N LYS A 47 SHEET 3 AA1 5 HIS A 68 ASP A 75 -1 O MET A 71 N MET A 58 SHEET 4 AA1 5 ASN A 115 GLU A 121 -1 O MET A 118 N LYS A 72 SHEET 5 AA1 5 LEU A 106 LYS A 111 -1 N PHE A 108 O VAL A 119 SHEET 1 AA2 2 LEU A 162 ILE A 163 0 SHEET 2 AA2 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 AA3 2 LEU A 172 ILE A 174 0 SHEET 2 AA3 2 ILE A 180 VAL A 182 -1 O GLN A 181 N LEU A 173 LINK C PHE A 138 N SEP A 139 1555 1555 1.33 LINK C SEP A 139 N GLU A 140 1555 1555 1.33 LINK C TRP A 196 N TPO A 197 1555 1555 1.33 LINK C TPO A 197 N LEU A 198 1555 1555 1.33 LINK C VAL A 337 N SEP A 338 1555 1555 1.33 LINK C SEP A 338 N ILE A 339 1555 1555 1.34 SITE 1 AC1 11 LEU A 49 VAL A 57 ALA A 70 GLU A 121 SITE 2 AC1 11 TYR A 122 VAL A 123 GLU A 127 GLU A 170 SITE 3 AC1 11 LEU A 173 PHE A 327 HOH A 642 SITE 1 AC2 4 VAL A 15 PHE A 18 GLU A 155 TYR A 306 CRYST1 52.270 71.967 97.982 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019131 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013895 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010206 0.00000